Follow-up Care After Treatment for Endometrial Cancer - Full Text View

Sponsors and Collaborators:	Ottawa Health Research Institute Ottawa Regional Cancer Centre
Information provided by:	Ottawa Health Research Institute
ClinicalTrials.gov Identifier:	NCT00750672

Purpose

The purposes of this study are to:

examine the needs (symptoms, support, information) and satisfaction of women during follow-up in the community after completing treatment for endometrial cancer. This information will be collected from the perspective of the women themselves, their primary care providers (family physician or gynecologist) and the health care providers (oncologist, nurses, social worker, psychologist) at the cancer centre.
determine the number of women who had their follow-up care transferred back to their primary care providers nd the number of women who needed to be referred back to the cancer centre and why.

Condition
Endometrial Neoplasm

MedlinePlus related topics: Cancer

Study Type:	Observational
Study Design:	Retrospective
Official Title:	Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.

Further study details as provided by Ottawa Health Research Institute:

Estimated Enrollment:	20
Study Start Date:	August 2008
Estimated Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Detailed Description:

Research Question How has this transfer in follow-up care impacted performance indicators?

Patient stakeholders:

What are women's perceptions of the transition of follow-up care?
What are women's supportive care needs during the transition of follow-up care and ongoing needs?

Primary Care Practitioner stakeholders:

What are the primary care practitioners' perceptions of the process of transition of follow-up care?
What are the primary care practitioners' educational needs?
What are the primary care practitioners' perceptions of the process of re-entry for in women with suspected recurrence?

Tertiary Centre: Health care providers stakeholders

What are the perceptions of tertiary health care providers about the transition of follow-up care?

Eligibility

Criteria

Inclusion Criteria:

Participants- women diagnosed with endometrial cancer:
- 18 years of age or older.
- speak English or French
- who have been treated (surgery and/or radiation therapy) at TOH.
- who have been discharged from follow-up in the cancer centre in the past 6 months.
Participants-primary care provider practitioner:
- providing follow-up care to at least one woman with endometrial cancer
Participants- health care providers at the tertiary centre :
- physicians, nurses or allied health care providers whose primary responsibility are to provide care to women with gynecological cancer.

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00750672

Locations

Canada, Ontario
The Ottawa Hospital	Recruiting
Ottawa, Ontario, Canada, K1H 8L6
Contact: Lynne Jolicoeur, MScN 6130737-8899 ext 72616 ljolicoeur@toh.on.ca
Principal Investigator: Lynne JA Jolicoeur, MScN

Sponsors and Collaborators

Ottawa Health Research Institute

Ottawa Regional Cancer Centre

More Information

No publications provided

Responsible Party:	OHRI ( Ms. Lynne Jolicoeur )
Study ID Numbers:	OHRI 2008-361, 2008361-01H for OHREB
Study First Received:	September 9, 2008
Last Updated:	September 9, 2008
ClinicalTrials.gov Identifier:	NCT00750672 History of Changes
Health Authority:	Canada: Health Canada

Keywords provided by Ottawa Health Research Institute:

Endometrial neoplasia
Follow-up care
survivorship
Primary care provider

Study placed in the following topic categories:

Genital Diseases, Female
Endometrial Neoplasms
Genital Neoplasms, Female
Uterine Diseases

Uterine Neoplasms
Endometrial Cancer
Urogenital Neoplasms

Additional relevant MeSH terms:

Genital Diseases, Female
Neoplasms
Endometrial Neoplasms
Neoplasms by Site

Genital Neoplasms, Female
Uterine Diseases
Uterine Neoplasms
Urogenital Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009